P eople with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both ...

Summary and Introduction Clinical Application—Disease Entities Theoretical Framework for Therapy−The 'Steel Paradigm' Conclusion References Theoretical Framework for Therapy−The 'Steel ...

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Chemoradiation (CRT), a combination of chemotherapy and radiotherapy, has been the standard treatment for cervical cancer ...

Researchers in London completed a long-term follow up of patients given a short course of chemotherapy before chemoradiation - a combination of chemotherapy and radiotherapy. The findings ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...

1 These data support the conclusion that patients who respond to preoperative chemoradiation therapy, who in this study were represented to a greater degree in the LAR group than in the APR group ...

Therapeutics and collaborators at The University of Texas MD Anderson Cancer Center presented late-breaking results from a Phase ...

Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...

Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.